Skip to main content

Advertisement

SpringerLink
Log in

Association of Rheumatoid Arthritis Risk Alleles with Response to Anti-TNF Biologics: Results from the CORRONA Registry and Meta-analysis

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

In this study, we investigated whether genetic variants known to be related with susceptibility to rheumatoid arthritis (RA) are also associated with response to therapy with anti-tumor necrosis factor (anti-TNF) biologics; 233 patients enrolled in the Consortium of Rheumatology Researchers of North America (CORRONA) RA registry were studied. Findings were combined with results from an international collaborative study (N = 1,283) in a meta-analysis (N = 1,516). Multivariate models investigating the association between single nucleotide polymorphisms (SNPs) and change in RA disease activity were adjusted for age, gender, concomitant methotrexate, and baseline disease activity. In the CORRONA cohort, nominal associations with disease activity improvement were observed for the rs1980422 SNP of the CD28 gene in multivariate models (coefficient −0.377, p = 0.005) but were not significant after adjustment for multiple comparisons (q = 0.10). In the meta-analysis, the only SNP with nominal associations with change in DAS28 was the rs2812378 SNP of the CCL21 gene (coefficient 1.9195, p = 0.0068). This association was not significant after adjustment for multiple comparisons (q = 0.143). We conclude that the established RA risk alleles studied were not significantly associated with response to anti-TNF biologics in the CORRONA cohort or the meta-analysis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kievit, W., E.M. Adang, J. Fransen, H.H. Kuper, M.A. van de Laar, T.L. Jansen, C.M. De Gendt, D.J. De Rooij, H.L. Brus, P.C. Van Oijen, and P.C. Van Riel. 2008. The effectiveness and medication costs of three anti-tumour necrosis factor alpha agents in the treatment of rheumatoid arthritis from prospective clinical practice data. Annals of the Rheumatic Diseases 67: 1229–1234.

    Article  PubMed  CAS  Google Scholar 

  2. Cui, J., S. Saevarsdottir, B. Thomson, L. Padyukov, A.H. van der Helm-van Mil, J. Nititham, L.B. Hughes, N. de Vries, S. Raychaudhuri, L. Alfredsson, J. Askling, S. Wedrén, B. Ding, C. Guiducci, G.J. Wolbink, J.B. Crusius, I.E. van der Horst-Bruinsma, M. Herenius, M.E. Weinblatt, N.A. Shadick, J. Worthington, F. Batliwalla, M. Kern, A.W. Morgan, A.G. Wilson, J.D. Isaacs, K. Hyrich, M.F. Seldin, L.W. Moreland, T.W. Behrens, C.F. Allaart, L.A. Criswell, T.W. Huizinga, P.P. Tak, S.L. Bridges Jr., R.E. Toes, A. Barton, L. Klareskog, P.K. Gregersen, E.W. Karlson, and R.M. Plenge. 2010. Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy. Arthritis and Rheumatism 62: 1849–1861.

    PubMed  CAS  Google Scholar 

  3. Kremer, J.M. 2006. The CORRONA database. Autoimmun Reviews 5: 46–54.

    Article  Google Scholar 

  4. Stahl, E.A., S. Raychaudhuri, E.F. Remmers, G. Xie, S. Eyre, B.P. Thomson, Y. Li, F.A. Kurreeman, A. Zhernakova, A. Hinks, C. Guiducci, R. Chen, L. Alfredsson, C.I. Amos, K.G. Ardlie, BIRAC Consortium, A. Barton, J. Bowes, E. Brouwer, N.P. Burtt, J.J. Catanese, J. Coblyn, M.J. Coenen, K.H. Costenbader, L.A. Criswell, J.B. Crusius, J. Cui, P.I. de Bakker, P.L. De Jager, B. Ding, P. Emery, E. Flynn, P. Harrison, L.J. Hocking, T.W. Huizinga, D.L. Kastner, X. Ke, A.T. Lee, X. Liu, P. Martin, A.W. Morgan, L. Padyukov, M.D. Posthumus, T.R. Radstake, D.M. Reid, M. Seielstad, M.F. Seldin, N.A. Shadick, S. Steer, P.P. Tak, W. Thomson, A.H. van der Helm-van Mil, I.E. van der Horst-Bruinsma, C.E. van der Schoot, P.L. van Riel, M.E. Weinblatt, A.G. Wilson, G.J. Wolbink, B.P. Wordsworth, YEAR Consortium, C. Wijmenga, E.W. Karlson, R.E. Toes, N. de Vries, A.B. Begovich, J. Worthington, K.A. Siminovitch, P.K. Gregersen, L. Klareskog, and R.M. Plenge. 2010. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nature Genetics 42: 508–514.

    Article  PubMed  CAS  Google Scholar 

  5. Raychaudhuri, S., E.F. Remmers, A.T. Lee, R. Hackett, C. Guiducci, N.P. Burtt, L. Gianniny, B.D. Korman, L. Padyukov, F.A. Kurreeman, M. Chang, J.J. Catanese, B. Ding, S. Wong, A.H. van der Helm-van Mil, B.M. Neale, J. Coblyn, J. Cui, P.P. Tak, G.J. Wolbink, J.B. Crusius, I.E. van der Horst-Bruinsma, L.A. Criswell, C.I. Amos, M.F. Seldin, D.L. Kastner, K.G. Ardlie, L. Alfredsson, K.H. Costenbader, D. Altshuler, T.W. Huizinga, N.A. Shadick, M.E. Weinblatt, N. de Vries, J. Worthington, M. Seielstad, R.E. Toes, E.W. Karlson, A.B. Begovich, L. Klareskog, P.K. Gregersen, M.J. Daly, and R.M. Plenge. 2008. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nature Genetics 40: 1216–1223.

    Article  PubMed  CAS  Google Scholar 

  6. Bentley, M.J., J.D. Greenberg, and G.W. Reed. 2010. A modified rheumatoid arthritis disease activity score without acute-phase reactants (mDAS28) for epidemiological research. Journal of Rheumatology 37: 1607–1614.

    Article  PubMed  Google Scholar 

  7. Green GH and Diggle PJ. On the operational characteristics of the Benjamini and Hochberg false discovery rate procedure. Stat Appl Genet Mol Biol 2007;6:Article27.

    Google Scholar 

  8. Normand, S.L. 1999. Meta-analysis: Formulating, evaluating, combining, and reporting. Statistics in Medicine 18: 321–359.

    Article  PubMed  CAS  Google Scholar 

  9. Klareskog, L., A.I. Catrina, and S. Paget. 2009. Rheumatoid arthritis. Lancet 373: 659–672.

    Article  PubMed  CAS  Google Scholar 

  10. Plenge, R.M. 2009. Recent progress in rheumatoid arthritis genetics: One step towards improved patient care. Current Opinion in Rheumatology 21: 262–271.

    Article  PubMed  Google Scholar 

  11. Potter, C., K.L. Hyrich, A. Tracey, M. Lunt, D. Plant, D.P. Symmons, W. Thomson, J. Worthington, P. Emery, A.W. Morgan, A.G. Wilson, J. Isaacs, A. Barton, and and the BRAGGSS. 2009. Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis. Annals of the Rheumatic Diseases 68: 69–74.

    Article  PubMed  CAS  Google Scholar 

  12. Tan, R.J., L.J. Gibbons, C. Potter, K.L. Hyrich, A.W. Morgan, A.G. Wilson, J.D. Isaacs, BRAGGSS, and A. Barton. 2010. Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment. Annals of the Rheumatic Diseases 69: 1029–1035.

    Article  PubMed  CAS  Google Scholar 

  13. Purcell, S., S.S. Cherny, and P.C. Sham. 2003. Genetic Power Calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19(1): 149–150.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Department of Medicine, New York Presbyterian Hospital, College of Physicians and Surgeons, Columbia University, P&S Building, Suite 10-455, New York, NY, 10032, USA

    Dimitrios A. Pappas

  2. Biostatistics, Department of Population Health, New York University School of Medicine, 650 First Avenue, #556, New York, NY, 10016, USA

    Cheongeun Oh

  3. Division of Rheumatology, Immunology and Allergy, Harvard Medical School, New Research Building (NRB), 77 Avenue Louis Pasteur, Boston, MA, 02115, USA

    Robert M. Plenge

  4. Department of Medicine, Albany Medical Center and The Center for Rheumatology, 1367 Washington Ave Ste 101, Albany, NY, 12206, USA

    Joel M. Kremer

  5. Department of Rheumatology, New York University Hospital for Joint Diseases, 301 East 17th Street, Suite 1410, New York, NY, 10003, USA

    Jeffrey D. Greenberg

Authors
  1. Dimitrios A. Pappas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cheongeun Oh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert M. Plenge
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joel M. Kremer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jeffrey D. Greenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dimitrios A. Pappas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pappas, D.A., Oh, C., Plenge, R.M. et al. Association of Rheumatoid Arthritis Risk Alleles with Response to Anti-TNF Biologics: Results from the CORRONA Registry and Meta-analysis. Inflammation 36, 279–284 (2013). https://doi.org/10.1007/s10753-012-9544-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-012-9544-4

KEY WORDS

Search

Navigation